OGT

New publication from Hamilton Health Sciences Center and London Health Sciences Center: 🔬 'Clinical outcomes in triple-negative myeloproliferative neoplasms with extreme thrombocytosis: A case series' In this study* the SureSeq™ Myeloid Sequencing Panel (OGT) was used as part of the next‑generation sequencing (NGS) workflow to identify somatic mutations (JAK2, CALR or MPL) in triple‑negative MPN patients with extreme thrombocytosis, supporting the study’s molecular characterisation of this rare patient subgroup. View the publication to learn more: tandfonline.com/doi/full/10.10… #ngs #sequencing #sureseq #ogt *Providing links to these publications is intended for educational purposes only and does not replace independent professional judgement. OGT does not endorse or approve, and assumes no responsibility for, the content, accuracy or completeness of the information presented in these publications.

🔎 NGS data spotlight – A study by Kingston Health Sciences Centre shows how OGT’s custom NGS panel for combined myeloid and lymphoid neoplasm analysis delivered comprehensive, efficient genomic insights, generated in a single assay. View the white paper to learn more: ogt.com/resources/ngs-… #NGSdataspotlight #myeloid #customNGS #myPanel #SureSeq #OGT SureSeq™: For Research Use Only; Not for Use in Diagnostic Procedures.

We were delighted to be a part of the latest HSJ Genomics Forum, where Graham Speight, EVP of R&D, presented the latest insights on how NGS-based MRD analysis could impact AML care pathways. We were grateful to be able to connect, share expertise and explore how we can move forward together to support the future of genomic clinical care with all participants. Missed our presentation? Don’t worry, you can see the original research data presentation, this is available on-demand from our AMP 2025 Workshop: ogt.com/resources/ngs-… #OGT #SureSeq #MRD #MeasurableResidualDisease #NGS #Hematology #HemeOnc #Oncology #CancerResearch #PrecisionMedicine

Innovation thrives when experts come together. 🔬✨ We recently hosted our Annual CytoCell® FISH UK User Group Meeting at our Oxford headquarters. It was a wonderful time to bring so many FISH professionals together to share insights and real-world experiences in advancing FISH technology.  A huge thank you to everyone who joined us!  #OGT #CytoCell #FISHprobes

That’s a wrap on #ACMGMtg26! Thank you to everyone who visited our booth, we really value the opportunity to connect, share expertise, and explore how we can support your future projects. Missed us at the meeting? You can learn more about our solutions and specialist support at ogt.com. #FISH #NGS #Genetics #CancerResearch

🔎 NGS data spotlight – A study by Kingston Health Sciences Centre shows how OGT’s optimisation of the bioinformatic analysis allowed for an increased resolution of copy number clonality findings down to 30%, during the development of a custom NGS panel for combined myeloid and lymphoid neoplasm analysis. View the white paper to learn more: ogt.com/resources/ngs-… #NGSdataspotlight #myeloid #customNGS #myPanel #SureSeq #OGT SureSeq™: For Research Use Only; Not for Use in Diagnostic Procedures.

CytoCell FDA-cleared FISH probes - developed by scientists, for scientists. Discover how our reliable, easy‑to‑use AML and MDS probes make generating high‑quality results simpler than ever. Join us at ACMG booth #911 to learn more from our team of experts. Book a meeting ow.ly/TPEA50Yoamr #ACMGMtg26 #Cytogenetics #CytoCell #FISH @TheACMG

In our latest article discover how Design of Experiments (DOE) can unlock smarter, more reliable NGS workflows. You’ll learn how DOE, a statistical method that optimises complex NGS workflows, analyses multiple parameters to shed light on the hidden interactions between them and how this can influence workflow outputs. Learn more here: ogt.com/resources/ngs-… #sureseq #doe #designofexperiments #sequencing #ngs #ngsworkflow #ogt

🔬 Discover CytoCell® at ACMG 2026 ​ A comprehensive portfolio of high-quality FISH probes designed for clear, confident detection of chromosomal abnormalities.​ 🔦Bright, reliable signals​ 🧪 Validated probe designs​ 🌍 Trusted by clinical cytogenetics labs worldwide​ 📍 Visit us at ACMG booth #911 to see how CytoCell® supports accurate diagnosis and confident reporting.​ Interested in learning more? Book a meeting with one of our experts surveymonkey.com/r/acmg-26-sm ​ @TheACMG #ACMGMtg26! #Cytogenetics #CytoCell #FISH

We’re back at #ACMGMtg26! Join us at booth #911 to: 🧬 Explore our CytoCell portfolio 💬 Talk with our experts 💡Learn how our cytogenetics and FISH solutions help deliver dependable results for both clinical and research applications Book a meeting with one of our experts: surveymonkey.com/r/acmg-26-sm #ACMGMtg26! #Cytogenetics #CytoCell #FISH #OGT

🔎NGS data spotlight – A study by Kingston Health Sciences Centre shows how OGT’s probe design optimisation significantly boosted target performance, during the development of a custom NGS panel for combined myeloid and lymphoid neoplasm analysis. View the white paper to learn more: ogt.com/resources/ngs-… #NGSdataspotlight #myeloid #customNGS #myPanel #SureSeq #OGT SureSeq™: For Research Use Only; Not for Use in Diagnostic Procedures.

Watch Sean Glenn, PhD (Director of Advanced Molecular Diagnostics Laboratory, Roswell Park Comprehensive Cancer Center) present data comparing the SureSeq™ Myeloid MRD Plus NGS Panel* to conventional MRD detection methods. View this session from AMP: ogt.com/resources/ngs-… #SureSeq #NGS #MRD #AML #OGT *SureSeq™: For Research Use Only. Not for use in diagnostic procedures.

📰 From sequencing to structural variants, the latest edition of our DNA Dispatch newsletter is here! This edition includes the latest news on the launch of our SureSeq™ Myeloid MRD Plus NGS Panel. Check out the newsletter: ogt.com/resources/dna-… #dnadispatch #ogtnews #ogtnewsletter #ogt

In this white paper, Kingston Health Sciences Centre detail their collaboration with OGT to develop a custom SureSeq myPanel™, designed to detect SNVs, indels, ITDs, PTDs and CNVs at both exon and whole-gene levels. Key outcomes from the study: 🧬 Comprehensive, efficient genomic insights generated in a single assay 🧬 OGT’s probe design optimisation significantly boosted target coverage 🧬 Robust analytical performance with 98% sensitivity and 100% specificity for SNV detection View the white paper: ogt.com/resources/ngs-… #myeloid #customNGS #myPanel #SureSeq #OGT SureSeq™: For Research Use Only; Not for Use in Diagnostic Procedures.

We’re at The Festival of Genomics & Biodata! 🧬 Come see us at Booth #152 to learn about how our range of FISH and NGS solutions empower your lab with precision. We look forward to connecting with you! #FOG2026 #OGT

Don’t miss our Live Lounge Presentation at The Festival of Genomics and Biodata London! 📅 Thursday, 29th January | 1:50-2:05 PM | Live Lounge Stage OGT’s Executive Vice President of R&D, Graham Speight, PhD, will share the latest evidence from a retrospective cohort research study using the SureSeq™ Myeloid MRD Plus NGS Panel*. Join us and learn how targeted NGS panels combined with refined bioinformatics can transform AML MRD analysis. *For Research Use Only; Not for Use in Diagnostic Procedures

Our NGS and FISH experts will be attending the Festival of Genomics & Biodata 2026 at the ExCeL London on 28th-29th January. Visit Booth 152 to learn how OGT’s genomic solutions can help you achieve more in haematology research and diagnostics 🧬 See you there! #FOG2026 #OGT